“A retrograde and unnecessary step”: FDA criticises new SCS performance management guidance
The FDA has criticised the government’s decision to delay the implementation of reforms to the performance management system for Senior Civil Servants (SCS), and the announcement that the existing performance management policy, with some adjustments, will apply for 2022/23. The adjustments will see those at SCS level ranked in one of four categories, with an expectation that 5% of staff will be ranked in the lowest category.
As reported by Civil Service World, FDA Assistant General Secretary Lucille Thirlby described the updated guidance as “a retrograde and unnecessary step”, adding that “it is hard to comprehend why any organisation would arbitrarily decide that 5% of its staff must be underperforming”.
In a message to FDA members in the Senior Civil Service, Thirlby further expressed her disappointment at the decision, and added that the FDA had made further representations to the Senior Salaries Review Body, making clear the union’s unhappiness at the approach:
“It is disappointing that all the work the Cabinet Office has undertaken to change and improve the Performance Management system will not be realised for another year.”
Related News
-
NICS reform can only be delivered with political leadership, says FDA
The FDA has called for strong political leadership to address the structural issues facing the Northern Ireland Civil Service, in response to the NI Audit Office report, ‘Capacity and Capability: Follow Up Report’.
-
FDA Ofsted report 2025: The people behind inspections
After a barrage of media criticism and calls for abolition, it’s been a difficult period for His Majesty’s Inspectors (HMI). Tommy Newell outlines the findings of the FDA’s recent report, revealing the reality of parents’ and educators’ views of Ofsted, and what HMIs need for an inspection system fit for the future.
-
